Modeling the intrathymic pathogenesis of myasthenia gravis

[1]  R. Mantegazza,et al.  The thymus in myasthenia gravis: Site of “innate autoimmunity”? , 2011, Muscle & nerve.

[2]  K. Kondo,et al.  Undiminished regulatory T cells in the thymus of patients with myasthenia gravis , 2010, Neurology.

[3]  L. Klein,et al.  Antigen presentation in the thymus for positive selection and central tolerance induction , 2009, Nature Reviews Immunology.

[4]  S. Berrih-Aknin,et al.  CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia , 2009, Annals of neurology.

[5]  R. Rojas-García,et al.  Treatment strategies for myasthenia gravis , 2009, Expert opinion on pharmacotherapy.

[6]  Patrice Nancy,et al.  Regulatory and Pathogenic Mechanisms in Human Autoimmune Myasthenia Gravis , 2008, Annals of the New York Academy of Sciences.

[7]  A. Levinson.  64 – Myasthenia gravis , 2008 .

[8]  R. Jonsson,et al.  The thymus is a source of B-cell-survival factors–APRIL and BAFF–in myasthenia gravis , 2006, Journal of Neuroimmunology.

[9]  S. Berrih-Aknin,et al.  The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. , 2006, Blood.

[10]  L. Klein,et al.  A central role for central tolerance. , 2006, Annual review of immunology.

[11]  P. Christadoss,et al.  Effects of Cytokines on Acetylcholine Receptor Expression: Implications for Myasthenia Gravis 1 , 2005, The Journal of Immunology.

[12]  A. Saoudi,et al.  Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. , 2005, Blood.

[13]  M. Sospedra,et al.  Different patterns of nicotinic acetylcholine receptor subunit transcription in human thymus , 2004, Journal of Neuroimmunology.

[14]  A. Levinson,et al.  Phenotypic characteristics of thymic B lymphocytes in myasthenia gravis , 1989, Journal of Clinical Immunology.

[15]  J. Todd,et al.  Scenarios for Autoimmunization of T and B Cells in Myasthenia Gravis , 2003, Annals of the New York Academy of Sciences.

[16]  A. Levinson,et al.  A New Model Linking Intrathymic Acetylcholine Receptor Expression and the Pathogenesis of Myasthenia Gravis , 2003, Annals of the New York Academy of Sciences.

[17]  J. Howard,et al.  Human thymuses express incomplete sets of muscle acetylcholine receptor subunit transcripts that seldom include the δ subunit , 2001, Muscle & nerve.

[18]  A. Levinson,et al.  Acetylcholine Receptor Alpha Subunit mRNA Expression in Human Thymus: Augmented Expression in Myasthenia Gravis and Upregulation by Interferon-γ , 1999 .

[19]  S. Berrih-Aknin,et al.  Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis. , 1996, Journal of immunology.

[20]  A. Khoruts,et al.  The anatomy of T-cell activation and tolerance. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. V. von Herrath,et al.  Role of viruses in the loss of tolerance to self-antigens and in autoimmune diseases. , 1995, Trends in microbiology.

[22]  S. Berrih-Aknin,et al.  Regulation of acetylcholine receptor alpha subunit variants in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction. , 1994 .

[23]  A. Levinson,et al.  Molecular Analysis of Intrathymic Nicotinic Acetylcholine Receptor , 1993, Annals of the New York Academy of Sciences.

[24]  A. Levinson,et al.  Molecular evidence for the expression of nicotinic acetylcholine receptor alpha-chain in mouse thymus. , 1992, Journal of immunology.

[25]  H. Spits,et al.  IL-1, IL-4, and IFN-gamma differentially regulate cytokine production and cell surface molecule expression in cultured human thymic epithelial cells. , 1991, Journal of immunology.

[26]  R. Ahmed,et al.  Abrogation of tolerance to a chronic viral infection. , 1991, Journal of Immunology.

[27]  J. Newsom-Davis,et al.  Acetylcholine receptor‐reactive T lymphocytes from healthy subjects and myasthenia gravis patients , 1991, Neurology.

[28]  M. Peuchmaur,et al.  In situ production of interleukins in hyperplastic thymus from myasthenia gravis patients. , 1991, Human pathology.

[29]  J. Sprent,et al.  Reentry of T cells to the adult thymus is restricted to activated T cells , 1991, The Journal of experimental medicine.

[30]  J. Löhler,et al.  Entry of antivirally active T lymphocytes into the thymus of virus-infected mice. , 1991, Journal of Immunology.

[31]  M. Oshima,et al.  Autoimmune T cell recognition of human acetylcholine receptor: the sites of T cell recognition in myasthenia gravis on the extracellular part of the α subunit , 1990, European journal of immunology.

[32]  A. Steck,et al.  Immunological heterogeneity of autoreactive T lymphocytes against the nicotinic acetylcholine receptor in myasthenic patients , 1990, European journal of immunology.

[33]  A. Levinson,et al.  Pokeweed mitogen-induced immunoglobulin secretory responses of thymic B cells in myasthenia gravis: selective secretion of IgG versus IgM cannot be explained by helper functions of thymic T cells. , 1990, Clinical immunology and immunopathology.

[34]  A. Vincent,et al.  The human muscle nicotinic acetylcholine receptor alpha‐subunit exist as two isoforms: a novel exon. , 1990, The EMBO journal.

[35]  K. Hirokawa,et al.  Immunohistological analysis of immigration of thymocyte-precursors into the thymus: evidence for immigration of peripheral T cells into the thymic medulla. , 1989, Cellular immunology.

[36]  E. A. Kirkpatrick,et al.  Rare peripheral T cells migrate to and persist in normal mouse thymus , 1988, The Journal of experimental medicine.

[37]  J. Lindstrom,et al.  Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides. , 1988, Journal of immunology.

[38]  H. Müller-Hermelink,et al.  Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. , 1988, The Journal of clinical investigation.

[39]  M. Schluep,et al.  Acetylcholine receptors in human thymic myoid cells in situ: An immunohistological study , 1987, Annals of neurology.

[40]  A. Roses,et al.  Thymectomy as Primary Therapy in Myasthenia Gravis , 1987, Annals of the New York Academy of Sciences.

[41]  R. Hohlfeld,et al.  Human T-helper lymphocytes in myasthenia gravis recognize the nicotinic receptor alpha subunit. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Levinson,et al.  Antibodies to acetylcholine receptor and tetanus toxoid: in vitro synthesis by thymic lymphocytes. , 1986, Journal of immunology.

[43]  Y. Monden,et al.  Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis. , 1986, Journal of immunology.

[44]  F. Arenzana‐Seisdedos,et al.  Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells. , 1985, Journal of immunology.

[45]  A. Levinson,et al.  Thymic B‐cell activation in myasthenia gravis , 1984, Neurology.

[46]  I. Cohen,et al.  Effector T lymphocyte line cells migrate to the thymus and persist there , 1982, Nature.

[47]  A. Levinson,et al.  COMPARATIVE IMMUNOGLOBULIN SYNTHESIS BY BLOOD LYMPHOCYTES OF MYASTHENICS AND NORMALS , 1981, Annals of the New York Academy of Sciences.

[48]  J. Newsom-Davis,et al.  Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes. , 1981, The New England journal of medicine.

[49]  S. Fuchs,et al.  Thymic lymphocytes bear a surface antigen which cross-reacts with acetylcholine receptor , 1980, Nature.

[50]  H. Wekerle,et al.  Intrathymic pathogenesis of myasthenia gravis: transient expression of acetylcholine receptors on thymus‐derived myogenic cells , 1978, European journal of immunology.

[51]  W. Engel,et al.  THYMIC EPITHELIAL CELL CONTAINS ACETYLCHOLINE RECEPTOR , 1977, The Lancet.

[52]  D. Drachman,et al.  Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis. , 1977, Science.